myelofibrosis

Imago BioSciences Advances Myelofibrosis Trials, With Phase IIb Prelim Readout Imminent
Imago BioSciences Advances Myelofibrosis Trials, With Phase IIb Prelim Readout Imminent
BioSpace
Imago
clinical trials
EHA
myelofibrosis
bomedemstat
Flag link:
Celgene wins approval for drug key to Bristol buyout
Celgene wins approval for drug key to Bristol buyout
Biopharma Dive
Celgene
FDA
Inrebic
myelofibrosis
M&A
Bristol-Myers Squibb
Flag link:
Sierra doubles down on ex-Gilead drug, deprioritizes other assets
Sierra doubles down on ex-Gilead drug, deprioritizes other assets
Fierce Biotech
Sierra Oncology
myelofibrosis
Gilead Sciences
momelotinib
Flag link:
Did Geron's Big Announcement Just Go Unnoticed?
Did Geron's Big Announcement Just Go Unnoticed?
Yahoo/Motley Fool
Geron
imetelstat
myelofibrosis
Flag link:
Sierra Oncology Acquires Gilead’s Stalled Myelofibrosis Drug
Sierra Oncology Acquires Gilead’s Stalled Myelofibrosis Drug
Xconomy
Gilead Sciences
Sierrra Oncology
myelofibrosis
momelotinib
Flag link:
A Huge Decision Is on Tap for This Little Biotech Stock
A Huge Decision Is on Tap for This Little Biotech Stock
Yahoo/Motley Fool
Geron
JNJ
imetelstat
myelofibrosis
Flag link:
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Endpoints
Sanofi
myelofibrosis
fedratinib
Impact Biomedicines
Flag link:
Gilead Fails to Beat Incyte’s Jakafi Drug
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Gilead Sciences
Jakafi
Incyte
momelotinib
myelofibrosis
Flag link:
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Endpoints
Shire
myelofibrosis
CTI BioPharma
Baxalta
M&A
pacritinib
Flag link:
Geron shares jump after two positive drug studies
Geron shares jump after two positive drug studies
Marketwatch
Geron
imetelstat
myelofibrosis
essential thrombocythemia
Flag link:
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
TheStreet.com
ASCO
CTI BioPharma
myelofibrosis
pacritinib
Jakafi
Incyte
Flag link:
Baxter and its controversial partner CTI claim a win in PhIII blood cancer study
Baxter and its controversial partner CTI claim a win in PhIII blood cancer study
Fierce Biotech
Baxter
CTI BioPharma
pacritinib
myelofibrosis
Flag link:
Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat
Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat
Bidness Etc.
JNJ
Geron
imetelstat
myelofibrosis
Flag link:
Incyte Building Blockbuster Drug One Disease At A Time
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Incyte
Jakafi
myelofibrosis
Flag link:
Geron Collaborates with J&J for Imetelstat
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Flag link:
Geron sells last drug in pipeline to J&J unit
Geron sells last drug in pipeline to J&J unit
Yahoo/Reuters
Geron
JNJ
imetelstat
Jakafi
myelofibrosis
Flag link:
After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed
After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed
TheStreet.com
Geron
myelofibrosis
imetelstat
Flag link:
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Yahoo
pacritinib
FDA
CTI BioPharma
fast track
myelofibrosis
Flag link:
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
Seeking Alpha
FDA
imetelstat
Geron
myelofibrosis
Flag link:
Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat
Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat
Seeking Alpha
Geron
imetelstat
myelofibrosis
Flag link:

Pages